{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:52:20Z","timestamp":1773071540042,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.euroneuro.2013.04.010","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T22:27:56Z","timestamp":1369261676000},"page":"1017-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching"],"prefix":"10.1016","volume":"23","author":[{"given":"Ofer","family":"Agid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Arenovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Sajeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krysta","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Foussias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagan","family":"Fervaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.04.010_bib1","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","article-title":"An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis","volume":"72","author":"Agid","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/jcp.0b013e3180d0a6d4","article-title":"Early use of clozapine for poorly responding first-episode psychosis","volume":"27","author":"Agid","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/JCP.0b013e31822c989a","article-title":"Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia: a 4-year follow-up naturalistic study","volume":"31","author":"Altamura","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib4","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","author":"American Psychiatric Association","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11632020-000000000-00000","article-title":"Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?","volume":"26","author":"Attard","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/YIC.0b013e3281084ea8","article-title":"Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study","volume":"22","author":"Barbui","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","article-title":"Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)","volume":"115","author":"Boter","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4088\/JCP.v65n0817","article-title":"Variables associated with high olanzapine dosing in a state hospital","volume":"65","author":"Botts","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2013.04.010_bib9","first-page":"4","article-title":"Strategies for dosing and switching antipsychotics for optimal clinical management","volume":"69","author":"Buckley","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib10","first-page":"1S","article-title":"Clinical practice guidelines: treatment of schizophrenia","volume":"50","author":"Canadian Psychiatric Association","year":"2005","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.psychres.2011.09.006","article-title":"Duration of untreated psychosis: relationship with baseline characteristics and three-year outcome in first-episode psychosis","volume":"198","author":"Chang","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4088\/JCP.v67n1004","article-title":"A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis","volume":"67","author":"Crespo-Facorro","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/JCP.0b013e3181d2193c","article-title":"Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?","volume":"30","author":"Derks","year":"2010","journal-title":"J. Clin. Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4088\/JCP.v67n1106","article-title":"Remission in first-episode psychosis: predictor variables and symptom improvement patterns","volume":"67","author":"Emsley","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/appi.ajp.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib16","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1176\/appi.ajp.163.12.2090","article-title":"Effectiveness of switching antipsychotic medications","volume":"163","author":"Essock","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib17","series-title":"Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-0179-2-11","article-title":"Pharmacological treatment of ambulatory schizophrenic patients in Belgium","volume":"2","author":"Hanssens","year":"2006","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.jcp.0000246215.49271.b8","article-title":"Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study","volume":"26","author":"Haro","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00406-012-0316-9","article-title":"Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial","volume":"262","author":"Kilian","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib21","first-page":"309","article-title":"Treatment of neuroleptic-resistant schizophrenic relapse","volume":"29","author":"Kinon","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/JCP.0b013e31817e63a5","article-title":"Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study","volume":"28","author":"Kinon","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S1461145710001380","article-title":"Evidence-based pharmacotherapy of schizophrenia","volume":"14","author":"Leucht","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib24","first-page":"92","article-title":"Treatment outcome of first episode schizophrenia","volume":"25","author":"Lieberman","year":"1989","journal-title":"Psychopharmacol. Bull."},{"issue":"Suppl 9","key":"10.1016\/j.euroneuro.2013.04.010_bib25","first-page":"5","article-title":"Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia","volume":"57","author":"Lieberman","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.schres.2010.03.023","article-title":"Where have all the women gone?: Participant gender in epidemiological and non-epidemiological research of schizophrenia","volume":"119","author":"Longenecker","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1991.01810320063009","article-title":"Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose","volume":"48","author":"McEvoy","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.v63n1006","article-title":"Risperidone, 2mg\/day vs. 4mg\/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning","volume":"63","author":"Merlo","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib31","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4088\/JCP.v68n1115","article-title":"The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update","volume":"68","author":"Moore","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib32","series-title":"NICE Clinical Guideline 82\u2014Schizophrenia","author":"National Institute of Clinical Excellence (NICE)","year":"2009"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib33","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00213-007-0730-2","article-title":"Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study","volume":"191","author":"Novick","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/bjp.185.1.18","article-title":"Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders","volume":"185","author":"Perkins","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib36","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2008.09.031","article-title":"Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial","volume":"107","author":"Rosenheck","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/bjp.bp.109.069328","article-title":"An early improvement threshold to predict response and remission in first-episode schizophrenia","volume":"196","author":"Schennach-Wolff","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s10488-007-0142-y","article-title":"Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications","volume":"34","author":"Sernyak","year":"2007","journal-title":"Adm. Policy Ment. Health"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0447.2006.00942.x","article-title":"Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors","volume":"116","author":"Simonsen","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1600-0447.2010.01598.x","article-title":"Early identification of non-remission in first-episode psychosis in a two-year outcome study","volume":"122","author":"Simonsen","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.psychres.2010.11.017","article-title":"Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis","volume":"187","author":"Stauffer","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.04.010_bib43","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4088\/JCP.v67n1013","article-title":"Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial","volume":"67","author":"Takahashi","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.pnpbp.2006.03.041","article-title":"Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial","volume":"30","author":"Takahashi","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.010_bib45","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1017\/S003329170800336X","article-title":"Predictors of outcome in first-episode schizophrenia over the first 4 years of illness","volume":"38","author":"Whitty","year":"2008","journal-title":"Psychol. Med."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T21:23:31Z","timestamp":1539638611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0924977X13001399"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.04.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}